# Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients

> **NCT03262584** · — · COMPLETED · sponsor: **Karius, Inc.** · enrollment: 40 (actual)

## Conditions studied

- Invasive Fungal Disease
- Fever and Neutropenia
- Invasive Fungal Infections
- Immunocompromised

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03262584
- **Lead sponsor:** Karius, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-17
- **Primary completion:** 2018-07-31
- **Final completion:** 2018-09-28
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03262584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03262584, "Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03262584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*